Business
Granules India Limited Press Release Jul 02 2026
Granules India Limited has informed the Exchange regarding a press release dated September 30, 2023, titled "Granules India Limited Received ANDA Approval for Losartan and Hydrochlorothiazide Tablets".

About this update from Granules India Limited
Granules India Limited has informed the Exchange regarding a press release dated September 30, 2023, titled "Granules India Limited Received ANDA Approval for Losartan and Hydrochlorothiazide Tablets". View Attachment
View stock analysis, news, and events for Granules India Limited